Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Beginning Of The End For Fossil Fuels Can Start In Colombia - 2Find the Keys to Fruitful Venture The board: Conveying Results on Time
- 3Sought-After Extravagance Ocean side Objections for a Lovely Escape
- 4Russia Fields New Ulan-2 All-Terrain Tactical Vehicle
- 5In blow to Lula, Brazil Congress revives controversial environmental bill
- 8 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN
- Poll: 62% of Americans would oppose U.S. military action in Greenland
- Weight-loss pill approval set to accelerate food industry product overhauls
- 21 Incredibly Interesting Contemplations To Observe Consistently
- CPA Canada appoints eight directors as new governance model takes effect
- Latvia seeks emergency UN meeting over Russian missile attack on Lviv
- 15 skywatching events you won't want to miss in 2026
- Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
- The Ascent of Rousing Pioneers Who Formed History
